Country Profile

Russia

Russia is one of India's largest pharmaceutical export destinations — $601M in FY 2025–26. Medicines accounts for 74% of shipments, with vaccines contributing $8.70M. The compound annual growth rate since FY2015 stands at 3.2%.

🇷🇺 #4 Destination · $601M · 1.4× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$601M
Exports FY2025–26 DGCIS
1.4×
Growth FY2015→2026
1.9%
Share of India Total
#4
Rank Among 178 Markets
3.2%
CAGR FY2015→2026
Russia is one of India's largest pharmaceutical export destinations — $601M in FY 2025–26. Medicines accounts for 74% of shipments, with vaccines contributing $8.70M. The compound annual growth rate since FY2015 stands at 3.2%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $446M (74.1%) Medicine Ingredients $103M (17.1%) Surgical & Hospital Supplies $24.6M (4.1%) Traditional & Herbal $19.2M (3.2%) Vaccines $8.70M (1.4%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Russia in the RBI overseas direct investment dataset (2011–2026).